@AshDombkowski

CEO and Co-Founder of Alladapt Immunotherapeutics

 San Francisco Bay Area
alladapt.com
Joined September 2011
  • Tweets954
  • Following1K
  • Followers739
36Media
Excited to share news of initiation of @alladaptimmuno 's first-in-patients Phase 1/2 clinical trial evaluating ADP101 for treatment of #foodallergy, enrolling patients across 20 sites in the US bit.ly/2RMW0aE
1
5
Ashley Dombkowski retweeted
SnackSafely.com@SnackSafely22 Nov 2023
More exciting news on the treatment front as @AlladaptImmuno receives FDA Fast Track designation for its OIT treatment that tackles #foodallergies to all Top 9 at the same time. snacksafely.com/2023/11/fda-…

FDA Fast Tracks Alladapt's ADP101 for the Treatment of Single and Multiple Food Allergies

Fast Track Designation accelerates ADP101's development path for the treatment of food allergies.

snacksafely.com
1
1
3
250
We're grateful for the opportunity to share promising results with the food allergy community at #ACAAI23! #ICYMI, read highlights from our Phase 1/2 Harmony Study evaluating ADP101 for the treatment of patients with mono- and multi- #FoodAllergy here: bit.ly/49rPSIh
1
1
179
ADP101 has received Fast Track designation from the FDA, marking an important milestone for people suffering from #FoodAllergy. We'll continue to work closely with the FDA to expedite development of this important therapy. Learn more in our press release: bit.ly/482MoL1
4
1
11
3,119
Ashley Dombkowski retweeted
Lianne Mandelbaum
@NoNutTraveler11 Nov 2023
Lake Travis HS teenager with #peanutallergy exposed to peanuts on purpose by high school football teammates.When we talk about the jokes about #foodallergies leading to IRL consequences this is a case in point. cbsaustin.com/news/local/lak… They spread peanut powder /peanut products on a fellow teammates locker and clothes. They knew about his allergy and even recorded the incident.The football players had to sit out for two regular season games as punishment, that's it. No suspension. No marks on their records, nothing. The jokes infuse into public consciousness & IMHO help perpetuate the leading myth that #allergies are not real. Utterly unacceptable.

Lake Travis HS teenager with severe allergies exposed to peanuts by high school teammates

A Lake Travis High School football player with severe allergies has a close call after he was intentionally exposed to peanuts by his teammates.The Lake Travis

cbsaustin.com
13
21
6
41
8,142
Our CEO @ashdombkowski will be speaking alongside other life science leaders this Friday at the @biocom CEO Summit. We look forward to connecting with our peers and discussing Alladapt's mission to help people with #FoodAllergies worldwide. #BiocomCEOSummit
1
2
128
Today, we're participating in the I&I panel at @Citi’s #BioPharma Conference in Boston. Food allergy affects 32m in the US alone; 95% lack treatments. Rapid clinical advances in #immunology are poised to change this. View the webcast: veracast.com/webcasts/citigr…
1
1
1
139
CFAAR's Dr. Ruchi Gupta and Dr. Chris Warren were co-authors in Dr. Kari Nadeau’s article, “Food allergy risks and dining industry – an assessment and a path forward.” Patients with #food allergies understand the challenges of dining out. Read more: bit.ly/3OHF2Wn
1
7
1,298
At Alladapt, we’re driven by our five core values, each of which motivate the Alladapt team to work together to improve the lives of those impacted by #foodallergy. Learn more about them: alladapt.com/#our-values
1
1
120
#ICYMI: Last month, Alladapt announced topline pediatric data from our Phase 1/2 Harmony Study evaluating ADP101 for the treatment of patients with mono- and multi-Food Allergy. #FoodAllergy Learn more: lnkd.in/egiK7GFS
1
1
107
Eating out with #foodallergies can be stressful, but don’t be afraid to speak up for yourself when it comes to food safety and your #foodallergy.
FARE | Food Allergy Research & Education
@FoodAllergy25 May 2023
Fear of judgment or messing up can make us not want to bring up our allergies, but it’s extremely important that we speak up for ourselves. Hear from TAG member Amelia Elliott about food allergy anxiety and ordering food: bit.ly/3kPybLA
1
191
Ashley Dombkowski retweeted
Peter Kolchinsky
@PeterKolchinsky3 Jul 2023
Three teenagers take action and get a law passed. Meanwhile, hundreds of thousands of adults working in biotech count on someone else to shape policy. Thank you to those who stand… 1/14
Lianne Mandelbaum
@NoNutTraveler2 Jul 2023
How three Greenwich teenagers helped get a CT bill on food allergies passed; 'We had to do something' greenwichtime.com/news/artic… via @GreenwichTime

How three Greenwich teenagers helped get a CT bill on food allergies passed; 'We had to do someth...

Robert Vine,16,  his sister Lilia, 15, and fellow Greenwich High School student Maia Coplit, 15, lobbied for state legislation about food allergies.

greenwichtime.com
1
8
1
35
49,920
Alladapt’s Co-founder and CEO @AshDombkowski spoke with @AllergicLiving recently about Alladapt’s promising P1/2 clinical data in #foodallergy. allergicliving.com/2023/06/2…

OIT Formula for Multiple Allergens Shows Promise in Early Results

OIT formula to treat multiple allergens shows promise in early study. 56% of kids were desensitized to up to 600 mg of 2 or more allergens.

allergicliving.com
1
1
2
652
Ashley Dombkowski retweeted
Allergic Living@AllergicLiving29 Jun 2023
Alladapt CEO @AshDombkowski speaks to us about promising early trial results in kids with the multi-allergy OIT formula ADP101. (Developed by Dr. Kari Nadeau.) "We saw people desensitizing to more than one allergen at a time." @AlladaptImmuno @Brian34Schroer #foodallergies

3
11
889
Today, Alladapt announced topline data from our Phase 1/2 Harmony Study evaluating ADP101 for the treatment of patients with mono- and multi- #FoodAllergy, as presented at the European Academy of Allergy and Clinical Immunology Hybrid Congress. #EAACI2023 assets.website-files.com/5e4…
1
3
232
Tomorrow morning, Dr. Shaila Gogate from @ColoradoAllergy and @CUMedicalSchool will give a flash talk on baseline characteristics from Alladapt’s Phase 1/2 Harmony Trial. #EAACI2023. More details here: eaaci.org/events_congress/ea…
1
2
184
Our clinical team is in Germany at the prestigious @EAACI_HQ Congress 2023, where our #clinicalstudy investigators will review topline results from our Phase 1/2 Harmony Trial evaluating ADP101 for the treatment of mono or multi #foodallergy. #EAACI2023 lnkd.in/ewJK_9Qm
1
4
269
Tomorrow, our CFO Glenn Reicin will present the Alladapt story at the @Jefferies Healthcare conference in New York City.
1
3
173
Alladapt’s Co-founder Dr. Kari Nadeau spoke with The @Guardian about #foodallergy around the world, the rise of #foodallergies and what a possible cure could look like. Listen here: theguardian.com/science/audi…

Why are food allergies on the rise and is a cure on the horizon? – podcast

Food allergies appear to be increasing globally, but as scientific understanding improves, some experts believe we may one day be able to eliminate them altogether. Ian Sample speaks to Dr Kari...

theguardian.com
1
3
113
We’re joining FARE (@foodallergy) during #foodallergyawarenessweek to raise awareness of #FA. Today, we honor health care providers who make a difference in the FA community. The work they do is invaluable in the lives of food allergy patients, family, friends & caregivers. #FAAW
1
1
224
Today, Alladapt announced the appointment of Louise Peacock as Chief Regulatory Affairs and Quality Officer. Louise has more than three decades of experience in drug development & regulatory approvals & we are excited to have her join our team. Learn more: assets.website-files.com/5e4…
1
1
115
Load more